Correction of facial lipoatrophy in HIV-infected patients on highly active antiretroviral therapy by injection of autologous fatty tissue

被引：28
|
作者：
Levan, P [1 ]
Nguyen, TH
Lallemand, F
Mazetier, L
Mimoun, M
Rozenbaum, W
Girard, PM
机构：
[1] Hop Rothschild, Serv Chirurg Plast & Reconstruct, F-75571 Paris, France
[2] Hop Rothschild, Serv Malad Infect & Trop, F-75012 Paris, France
[3] Hop Rothschild, Serv Radiol, F-75571 Paris, France
[4] Hop St Antoine, Serv Malad Infect & Trop, F-75571 Paris, France
来源：
AIDS | 2002年 / 16卷 / 14期
关键词：
D O I：
10.1097/00002030-200209270-00026
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1985 / 1987
页数：3
相关论文
共 50 条
  • [41] Facial fat volume in HIV-infected patients with lipoatrophy
    Yang, Y
    Sitoh, YY
    Tha, NO
    Paton, NI
    ANTIVIRAL THERAPY, 2005, 10 (04) : 575 - 581
  • [42] Clinical classification of facial lipoatrophy in HIV-infected patients
    Fontdevila, J
    Milinkovic, A
    Martinez, E
    Yoon, TS
    Gatell, JM
    Serra, JM
    ANTIVIRAL THERAPY, 2003, 8 (04) : L81 - L81
  • [43] High Prevalence and Impact on the Quality of Life of Facial Lipoatrophy and Other Abnormalities in Fat Tissue Distribution in HIV-Infected Patients Treated with Antiretroviral Therapy
    Leclercq, Pascale
    Goujard, Cecile
    Duracinsky, Martin
    Allaert, Francois
    L'Henaff, Marianne
    Hellet, Maeva
    Meunier, Jean Pierre
    Carret, Sophie
    Thevenon, Jacques
    Philippe Ngo Van
    Pialoux, Gilles
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (05) : 761 - 768
  • [44] Thromboses among HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era
    Crum-Cianflone, Nancy F.
    Weekes, Jhamillia
    Bavaro, Mary
    AIDS PATIENT CARE AND STDS, 2008, 22 (10) : 771 - 778
  • [45] Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy
    Dunic, I
    Vesic, S
    Jevtovic, DJ
    HIV MEDICINE, 2004, 5 (01) : 50 - 54
  • [46] Diverse dermatologic manifestations in HIV-infected patients after highly active antiretroviral therapy
    Jutivorakool, K.
    Plussind, P.
    Choengwiwatkit, H.
    Waiwarawut, J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S152 - S152
  • [47] Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain
    Benito, N
    Rañó, A
    Moreno, A
    González, J
    Luna, M
    Agustí, C
    Danés, C
    Pumarola, T
    Miró, JM
    Torres, A
    Gatell, JM
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 27 (01) : 35 - 43
  • [48] Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients
    Palella, FJ
    Chmiel, JS
    Moorman, AC
    Holmberg, SD
    AIDS, 2002, 16 (12) : 1617 - 1626
  • [49] Osteonecrosis in HIV-infected patients and its correlation with highly active antiretroviral therapy (HAART)
    Calza, L
    Manfredi, R
    Chiodo, F
    PRESSE MEDICALE, 2003, 32 (13): : 595 - 598
  • [50] Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients
    Revankar, SG
    Sanche, SE
    Dib, OP
    Caceres, M
    Patterson, TF
    AIDS, 1998, 12 (18) : 2511 - 2513
12345